EP2645106

BIOGEN IDEC MA INC.
Application Number
EP13158951A
Filing Date
Apr 4, 2006
Status
Patent Maintained As Amended
Aug 30, 2024
Grant Date
Oct 2, 2024
External Links
Slate, Register

Biblio Summary

The patent EP2645106B2 was granted on Oct 2, 2024 by Biogen Idec Ma Inc. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PHARMACEUTICAL WORKS POLPHARMA SAMar 9, 2018ADMISSIBLE

The table below shows the patents of Biogen Idec Ma Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2701778A Limiter For A Dispensing DeviceOct 18, 20232
EP2653873Compositions And Uses For Treating Multiple SclerosisAug 24, 202214
EP2870250Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses ThereofJun 29, 20222